Halle (Saale) and Munich, Germany // Probiodrug AG, a biopharmaceutical company focusing on the development of small molecule inhibitors for the treatment of inflammatory and neurodegenerative […]
Dr. Christoph Schröder, Dr. Erich Platzer and Dr. Dinnies von der Osten join Supervisory Board Halle (Saale) and Munich, Germany // Probiodrug AG, a developer of […]
Combined Entity Raises Euro 20.6 Million in Series A Funding Halle (Saale) and Munich, Germany // Probiodrug AG, a developer of small molecule inhibitors against inflammatory […]
Halle (Saale) and Munich , Germany // Probiodrug AG Privately held Probiodrug AG of Halle/Saale, Germany, announced today the closing of its Series C Financing Round […]
Halle (Saale) / Germany / Probiodrug AG Probiodrug AG announced today the expansion of the Scientific Advisory Board of the company and the appointment of Dr. […]
Halle (Saale), Germany // Probiodrug AG Probiodrug AG announced today the expansion of the Scientific Advisory Board of the company and the appointment of Prof. Dr. […]
Halle (Saale), Germany // Probiodrug AG Morphochem AG and Probiodrug AG today announced that they have entered into a research and collaboration for the development of […]
Halle (Saale), Germany // Probiodrug AG Probiodrug announced today that all closing conditions to finalize the Probiodrug-Prosidion transaction have been fulfilled. In connection with the transaction, […]
Halle (Saale), Germany // Probiodrug AG, a drug development company, has been awarded a €1.9mio grant from the German Federal Department of Education and Research under […]